Daniel J. Sall

900 total citations
29 papers, 561 citations indexed

About

Daniel J. Sall is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, Daniel J. Sall has authored 29 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Organic Chemistry and 7 papers in Hematology. Recurrent topics in Daniel J. Sall's work include Chemical Synthesis and Analysis (10 papers), Synthesis and Biological Activity (7 papers) and Click Chemistry and Applications (5 papers). Daniel J. Sall is often cited by papers focused on Chemical Synthesis and Analysis (10 papers), Synthesis and Biological Activity (7 papers) and Click Chemistry and Applications (5 papers). Daniel J. Sall collaborates with scholars based in United States and United Kingdom. Daniel J. Sall's co-authors include Gary L. Grunewald, Christopher M. Moxham, Mark Uhlik, Dirk Tomandl, Jonathan A. Lee, James A. Monn, Donetta S. Gifford‐Moore, Gerald F. Smith, A. Richard Chamberlin and Milana Dezube and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Daniel J. Sall

29 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel J. Sall United States	14	279	251	72	54	51	29	561
Christian Krog-Jensen Sweden	12	323 1.2×	345 1.4×	54 0.8×	37 0.7×	30 0.6×	16	547
Dominick Mobilio United States	9	132 0.5×	278 1.1×	63 0.9×	78 1.4×	85 1.7×	13	544
James E. Sheppeck United States	15	296 1.1×	313 1.2×	24 0.3×	72 1.3×	53 1.0×	24	628
Cleo J. C. Connolly United States	10	506 1.8×	352 1.4×	33 0.5×	48 0.9×	21 0.4×	13	802
Stephen E. de Laszlo United States	16	482 1.7×	394 1.6×	42 0.6×	41 0.8×	33 0.6×	28	786
Paul A. Tuthill United States	9	149 0.5×	167 0.7×	24 0.3×	54 1.0×	49 1.0×	14	371
Dramane I. Lainé United States	14	238 0.9×	193 0.8×	50 0.7×	25 0.5×	14 0.3×	29	528
Roberta Tesch Germany	14	217 0.8×	263 1.0×	63 0.9×	32 0.6×	39 0.8×	20	520
Jung-Mi Hah South Korea	15	324 1.2×	247 1.0×	39 0.5×	30 0.6×	20 0.4×	21	504
Raymond J. Patch United States	16	396 1.4×	448 1.8×	33 0.5×	48 0.9×	36 0.7×	30	902

Countries citing papers authored by Daniel J. Sall

Since Specialization

Citations

This map shows the geographic impact of Daniel J. Sall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Sall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Sall more than expected).

Fields of papers citing papers by Daniel J. Sall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. Sall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Sall. The network helps show where Daniel J. Sall may publish in the future.

Co-authorship network of co-authors of Daniel J. Sall

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. Sall. A scholar is included among the top collaborators of Daniel J. Sall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. Sall. Daniel J. Sall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Jonathan A., Mark Uhlik, Christopher M. Moxham, Dirk Tomandl, & Daniel J. Sall. (2012). Modern Phenotypic Drug Discovery Is a Viable, Neoclassic Pharma Strategy. Journal of Medicinal Chemistry. 55(10). 4527–4538. 134 indexed citations

Stevens, Frits C., Marlene L. Cohen, Mark L. Heiman, et al.. (2007). Potent oxindole based human β3 adrenergic receptor agonists. Bioorganic & Medicinal Chemistry Letters. 17(22). 6270–6273. 43 indexed citations

Klimkowski, Valentine J., Brian M. Watson, Michael R. Wiley, et al.. (2007). d-Phenylglycinol-derived non-covalent factor Xa inhibitors: Effect of non-peptidic S4 linkage elements on affinity and anticoagulant activity. Bioorganic & Medicinal Chemistry Letters. 17(21). 5801–5805. 6 indexed citations

Bell, Michael G., Marlene L. Cohen, Mark L. Heiman, et al.. (2006). Potent benzimidazolone based human β3-adrenergic receptor agonists. Bioorganic & Medicinal Chemistry Letters. 16(21). 5691–5694. 6 indexed citations

Sall, Daniel J., et al.. (2000). The crystal structures of human α‐thrombin complexed with active site‐directed diamino benzo[b] thiophene derivatives: A binding mode for a structurally novel class of inhibitors. Protein Science. 9(1). 29–36. 16 indexed citations

Takeuchi, Kumiko, Donetta S. Gifford‐Moore, Richard W. Harper, et al.. (2000). 1,2-disubstituted indole, azaindole and benzimidazole derivatives possessing amine moiety: a novel series of thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(20). 2347–2351. 28 indexed citations

Takeuchi, Kumiko, Todd J. Kohn, Richard W. Harper, et al.. (2000). Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. Part 6: Further focus on the contracted C4′-side chain analogues. Bioorganic & Medicinal Chemistry Letters. 10(11). 1199–1202. 3 indexed citations

Chirgadze, Nickolay Y., et al.. (1999). Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 3. Enhancing activity by imposing conformational restriction in the C-4″ side chain1. Bioorganic & Medicinal Chemistry Letters. 9(3). 363–368. 4 indexed citations

Takeuchi, Kumiko, et al.. (1999). Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 4. SAR studies on the conformationally restricted C3-side chain of hydroxybenzo[b]thiophenes. Bioorganic & Medicinal Chemistry Letters. 9(5). 759–764. 28 indexed citations

10.

Bronson, D, Donetta S. Gifford‐Moore, Michael P. Lynch, et al.. (1999). Solid phase chemistry approach to the SAR development of a novel class of active site-directed thrombin inhibitors. Tetrahedron. 55(39). 11641–11652. 8 indexed citations

11.

Sall, Daniel J., Steve Briggs, Nickolay Y. Chirgadze, et al.. (1998). Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 2. Exploring interactions at the proximal (S2) binding site. Bioorganic & Medicinal Chemistry Letters. 8(18). 2527–2532. 8 indexed citations

12.

Sall, Daniel J., Ann Arfsten, Jefferson R. McCowan, et al.. (1997). Use of Conformationally Restricted Benzamidines as Arginine Surrogates in the Design of Platelet GPIIb-IIIa Receptor Antagonists. Journal of Medicinal Chemistry. 40(18). 2843–2857. 15 indexed citations

13.

Sall, Daniel J., Ann Arfsten, Jefferson R. McCowan, et al.. (1996). Platelet glycoprotein IIb–IIIa receptor (GPIIb–IIIa) antagonists derived from amidinoindoles. Bioorganic & Medicinal Chemistry Letters. 6(1). 81–86. 4 indexed citations

14.

Sall, Daniel J. & R. E. Kaiser. (1993). Characterization of the interaction between human .alpha.-thrombin and methyl 3-(2-methyl-1-oxopropoxy) [1]benzothieno[3,2-b]furan-2-carboxylate (LY806303) using electrospray mass spectrometry and tandem mass spectrometry. Journal of Medicinal Chemistry. 36(16). 2350–2355. 9 indexed citations

15.

Grunewald, Gary L., et al.. (1990). ONE-STEP SYNTHESIS OF TRIFLUOROMETHYL- AND OF METHOXY-SUBSTITUTED BENZYNE PRECURSORS. Organic Preparations and Procedures International. 22(6). 747–753. 3 indexed citations

16.

Grunewald, Gary L., et al.. (1988). Conformational preference for the binding of biaryl substrates and inhibitors to the active site of phenylethanolamine N-methyltransferase (PNMT). Journal of Medicinal Chemistry. 31(1). 60–65. 7 indexed citations

17.

Grunewald, Gary L., Daniel J. Sall, & James A. Monn. (1988). Conformationally defined adrenergic agents. 13. Conformational and steric aspects of the inhibition of phenylethanolamine N-methyltransferase by benzylamines. Journal of Medicinal Chemistry. 31(2). 433–444. 23 indexed citations

18.

Grunewald, Gary L., Daniel J. Sall, & James A. Monn. (1988). Synthesis and evaluation of 3-substituted analogs of 1,2,3,4-tetrahydroisoquinoline as inhibitors of phenylethanolamine N-methyltransferase. Journal of Medicinal Chemistry. 31(4). 824–830. 31 indexed citations

19.

Grunewald, Gary L., et al.. (1987). Conformationally defined adrenergic agents. 10. Binding orientation of amphetamine and norfenfluramine analogs in the benzonorbornene and benzobicyclo[3.2.1]octane ring systems at the active site of phenylethanolamine N-methyltransferase (PNMT). Journal of Medicinal Chemistry. 30(12). 2191–2208. 12 indexed citations

20.

Sall, Daniel J. & Gary L. Grunewald. (1987). Inhibition of phenylethanolamine N-methyltransferase (PNMT) by aromatic hydroxy-substituted 1,2,3,4-tetrahydroisoquinolines. Further studies on the hydrophilic pocket of the aromatic ring binding region of the active site. Journal of Medicinal Chemistry. 30(12). 2208–2216. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact